Malignant Melanoma Terminated Phase 1 / 2 Trials for Cyclophosphamide (DB00531)

Also known as: Melanoma, Malignant / [M]Malignant melanoma NOS (morphologic abnormality) / Melanoma / Malignant melanoma (morphologic abnormality) / Malignant melanoma (disorder) / [M]Malignant melanoma NOS or melanocarcinoma or melanoma NOS / Melanoma: [skin] or [malignant] / Melanoma malignant

IndicationStatusPhase
DBCOND0029825 (Malignant Melanoma)Terminated1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00924001Chemotherapy Followed by Infusion of DMF5 Cells to Treat Metastatic MelanomaTreatment